Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Syuichi Ikeda"'
Autor:
Shouji Ine, Shuming Chen, Syuichi Ikeda, Junichi Kameoka, Hideo Harigae, Takeshi Sasaki, Naoto Ishii, Pejman Soroosh, Noriyuki Kasai, Lishomwa C. Ndhlovu, Kazuo Sugamura, Taku Fujimura, Kohtaro Tada
Publikováno v:
International Immunology. 18:269-277
Adult T cell leukemia (ATL) is an aggressive neoplastic disease, in which a quarter of the patients develop opportunistic infections due to cellular immunodeficiency. However, the underlying mechanism responsible for the immunosuppression has remaine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b217046f41fb51ccfe026afc4389265
https://doi.org/10.1093/intimm/dxh366
https://doi.org/10.1093/intimm/dxh366
Autor:
Kenji, Ishitsuka, Syuichi, Ikeda, Youichiro, Izumi, Yutaka, Imamura, Naokuni, Uike, Kimiharu, Uozumi, Atae, Utsunomiya, Fumio, Kawano, Youko, Kubuki, Hisashi, Gondo, Yoshio, Saburi, Tsunefumi, Sibuya, Jin, Suzusima, Jyunichi, Tsukada, Makoto, Hayashi, Kouichi, Maeda, Eijyo, Matuishi, Hitoshi, Matsuoka, Sigeyoshi, Makino, Kazuo, Tamura
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 44(7)
The Kyushu Hematology Organization for Treatment Study Group (K-HOT) consisted of 22 institutions specializing in hematology in Kyushu. This study is aimed at reviewing the daily practice of infection control for the treatment of hematological malign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6177a02052fc8e1cb4a82edb70ea5b36
https://pubmed.ncbi.nlm.nih.gov/12931571
https://pubmed.ncbi.nlm.nih.gov/12931571
Autor:
Masato Masuda, T. Hotta, Atae Utsunomiya, Masanori Shimoyama, Takuya Fukushima, Masao Tomonaga, Haruhiko Fukuda, Syuichi Ikeda, Kunihiro Tsukasaki, Kensei Tobinai
Publikováno v:
Blood. 106:812-812
Background: In our study for non-Hodgkin lymphoma (NHL) in 1980’s (JCOG8701), human T-lymphotropic virus type-1- associated ATLL was the poorest prognostic subtype in NHL. The complete response (CR) rate was 42%, the median survival time (MST) was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3ef67be6bee9b8f54c5789fdd804acb
https://doi.org/10.1182/blood.v106.11.812.812
https://doi.org/10.1182/blood.v106.11.812.812
Autor:
Shuming Chen, Naoto Ishii, Shouji Ine, Syuichi Ikeda, Taku Fujimura, Lishomwa C. Ndhlovu, Pejman Soroosh, Kohtaro Tada, Hideo Harigae, Junichi Kameoka, Noriyuki Kasai, Takeshi Sasaki, Kazuo Sugamura
Publikováno v:
International Immunology; Feb2006, Vol. 18 Issue 2, p269-277, 9p
Periodical
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.